COVID-19 Cases and Deaths, Vaccinations, and Treatments by Race/Ethnicity as of Fall 2022


As the US enters its third vacation season navigating a possible enhance in COVID-19 circumstances in addition to other respiratory illnesses, federal information from the Facilities for Illness Management and Prevention (CDC) present that as of November 9, 2022, 80% of the overall inhabitants in the US have acquired at the least one dose of a COVID-19 vaccine and solely 10% of eligible people have acquired the up to date, bivalent booster that was authorized to be used amongst people 5 years of age and older in early Fall 2022. People who’ve not received any booster dose are at greater threat of an infection from the virus, and individuals who stay unvaccinated proceed to be at particularly high risk for extreme sickness and demise.

Over the course of the pandemic, racial disparities in circumstances and deaths have widened and narrowed. Nonetheless, total, Black, Hispanic, and American Indian and Alaska Native (AIAN) individuals have borne the heaviest well being impacts of the pandemic, significantly when adjusting information to account for variations in age by race and ethnicity. Whereas Black and Hispanic individuals had been much less probably than their White counterparts to obtain a vaccine in the course of the preliminary phases of the vaccination rollout, these disparities have narrowed over time and reversed for Hispanic individuals. Regardless of this progress, a vaccination hole persists for Black individuals. COVID-19 outpatient therapies, which may mitigate hospitalization and demise from COVID-19, are additionally out there. Nonetheless, early information recommend racial disparities in access to and receipt of these therapies.

This information notice presents an replace on the standing of COVID-19 circumstances and deaths, vaccinations, and coverings by race/ethnicity as of Fall 2022, primarily based on federal information reported by the Facilities for Illness Management and Prevention (CDC).

What’s the standing of COVID-19 circumstances and deaths by race/ethnicity?

Racial disparities in COVID-19 circumstances and deaths have widened and narrowed over the course of the pandemic, however when information are adjusted to account for variations in age by race/ethnicity, they present that AIAN, Black, and Hispanic individuals have had greater charges of an infection and demise than White individuals over many of the course of the pandemic. Early within the pandemic, there have been massive racial disparities in COVID-19 circumstances. Disparities narrowed when total an infection charges fell. Nonetheless, in the course of the surge related to the Omicron variant in Winter 2022, disparities in circumstances as soon as once more widened with Hispanic (4,341 per 100,000), AIAN (3,818 per 100,000), Black (2,937 per 100,000), and Asian (2,755 per 100,000) individuals having greater age-adjusted an infection charges than White individuals (2,693 per 100,000) as of January 2022 (Determine 1). Following that surge, an infection charges fell in Spring 2022 and disparities have as soon as once more narrowed. Nonetheless, as of September 2022, the age-adjusted COVID-19 an infection charges had been nonetheless highest for Black and Hispanic individuals (192 per 100,000 for every group), adopted by AIAN individuals at 188 per 100,000. White and Asian individuals had the bottom an infection charges at 164 per 100,000 and 153 per 100,000, respectively. Whereas demise charges for many teams of coloration had been considerably greater in contrast with White individuals early on within the pandemic, since late Summer time 2020, there have been some durations when demise charges for White individuals have been greater than or much like some teams of coloration. Nonetheless, age-adjusted information present that AIAN, Black, and Hispanic individuals have had greater charges of demise in contrast with White individuals over many of the pandemic and significantly throughout surges. For instance, as of January 2022, amid the Omicron surge, age-adjusted demise charges had been greater for Black (37.4 per 100,000), AIAN (34.7 per 100,000), and Hispanic individuals (29.9 per 100,000) in contrast with White individuals (23.5 per 100,000) (Determine 1). Following that surge, disparities narrowed when demise charges fell. As of August 2022, age-adjusted demise charges had been comparable for AIAN (4.9 per 100,000), Black (4.4 per 100,000), and White individuals (4.2 per 100,000) and decrease for Hispanic (3.6 per 100,000) and Asian (2.7 per 100,000) individuals. Regardless of these fluctuations over time, whole cumulative age-adjusted data proceed to point out that Black, Hispanic, and AIAN individuals have been at greater threat for COVID-19 circumstances, hospitalizations, and deaths in contrast with White individuals.

What are COVID-19 vaccination and booster patterns by race/ethnicity?

Whereas disparities in COVID-19 vaccinations have narrowed over time and have been reversed for Hispanic individuals, they persist for Black individuals. Ongoing KFF analysis exhibits that at each the federal and state stage, there have been massive gaps in vaccination for Black and Hispanic individuals within the preliminary phases of the vaccination rollout, which narrowed over time and ultimately reversed for Hispanic individuals. Regardless of this progress, a vaccination hole persists for Black individuals. In line with the CDC, total, 80% of individuals had acquired at the least one COVID-19 vaccination dose as of November 9, 2022, and race/ethnicity was recognized for 75% of people that had acquired at the least one dose. Based mostly on these with recognized race/ethnicity, about half (50%) of Black individuals had acquired at the least one dose in contrast with 56% of White individuals, two-thirds (66%) of Hispanic individuals, and over seven in ten Native Hawaiian and different Pacific Islander (NHOPI) (70%), Asian (72%), and AIAN (77%) individuals (Determine 2).

General, few individuals have acquired the up to date bivalent booster vaccine dose, and Black and Hispanic individuals are about half as probably as White individuals to have acquired this booster to this point. The up to date bivalent boosters shield towards each the unique virus that causes COVID-19 and the BA.4 and BA.5 Omicron variants. These boosters turned out there for individuals ages 12 years and older on September 2, 2022, and for individuals ages 5-11 years previous on October 12, 2022. The CDC recommends that individuals ages 5 years and older obtain one bivalent booster at the least 2 months after their final COVID-19 vaccine dose. The CDC reports that, total, 10% of individuals over age 5 have acquired the up to date bivalent booster vaccine dose as of November 9, 2022, with race/ethnicity information out there for 88%. Based mostly on these with recognized race/ethnicity, 11% of eligible Asian and 10% of eligible White individuals had acquired a bivalent booster dose, roughly twice the shares of eligible Black (5%) and Hispanic individuals (4%) (Determine 2). The bivalent booster dose fee was 6% for eligible NHOPI individuals and eight% for eligible AIAN individuals.

What are COVID-19 remedy patterns by race/ethnicity?

New information from CDC present racial disparities in receipt of COVID-19 oral antiviral therapies, together with Paxlovid, probably the most broadly prescribed antiviral. As of November 2022, there are four COVID-19 outpatient treatments, together with: Paxlovid and Lagevrio, oral antivirals that had been each authorized in December 2021; Veklury, an IV infusion antiviral that was authorized in January 2021; and Bebtelovimab a monoclonal antibody that was authorized in February 2022. Outpatient COVID-19 therapies are really useful for individuals who have examined optimistic for COVID-19 with gentle to average signs and who’re at excessive threat of creating extreme sickness. Prior KFF analysis pointed to potential disparities in entry to COVID-19 therapies for counties with the very best poverty charges and people which are majority Black, Hispanic, and AIAN. Different analyses have documented disparities in monoclonal antibody treatments by race and ethnicity in addition to disparities in oral antiviral remedy by zip-code vulnerability. An October 2022 CDC Morbidity and Mortality Weekly Report provides to those findings displaying that, via July 2022, individuals of coloration had been much less prone to obtain at present out there outpatient antiviral COVID-19 therapies in contrast with their White counterparts. Particularly, between April to July 2022, the share of COVID-19 sufferers aged 20 years and older handled with Paxlovid was decrease amongst Black (21%) and Hispanic (21%) sufferers than amongst White (32%) and non-Hispanic (30%) sufferers, respectively (Determine 3). The shares of AIAN and NHOPI (25%) and Asian (26%) sufferers receiving prescriptions had been additionally smaller in comparison with the share of White sufferers. These disparities had been noticed throughout all age teams and had been extra evident amongst adults ages 50 and older and immunocompromised sufferers. Racial and ethnic disparities existed for remedy with different drugs, however variations had been small given total low ranges of remedy with these different drugs.

Dialogue

Whereas disparities in circumstances and deaths have widened and narrowed over the course of the pandemic, age-adjusted information present that AIAN, Black, and Hispanic individuals have had greater charges of circumstances and demise in contrast with White individuals over many of the course of the pandemic and that they’ve skilled total greater charges of an infection, hospitalization, and demise.

Knowledge level to considerably elevated dangers of COVID-19 sickness and demise for individuals who stay unvaccinated or have not received an updated bivalent booster dose. In the course of the preliminary vaccine rollout, Black and Hispanic individuals had been much less prone to obtain vaccines than their White counterparts. Nonetheless, these disparities have narrowed over time and reversed for Hispanic individuals, although they persist for Black individuals. Regardless of this progress in preliminary vaccination uptake, total uptake of the up to date bivalent booster dose has been sluggish to this point, and there have been racial disparities in receipt of those booster doses, with eligible Black, Hispanic, and NHOPI individuals about half has prone to have acquired an up to date booster than their White counterparts. Knowledge additionally level to disparities in receipt of COVID-19 therapies, with sufferers of coloration much less prone to obtain oral antivirals, together with Paxlovid, in comparison with White sufferers.

General, these information present that though the pandemic has contributed to rising consciousness and concentrate on addressing racial disparities, they persist, reflecting the underlying structural inequities that drive them. The findings spotlight the significance of a continued concentrate on fairness and efforts to deal with inequities that depart individuals of coloration at elevated threat for publicity, sickness, and demise in addition to to shut gaps in entry to well being care, together with COVID-19 therapies. Addressing these gaps is of accelerating significance as these disparities could also be exacerbated when federal funding for COVID-19 vaccines, therapies, and exams runs out and a few individuals could face elevated out-of-pocket prices to entry these companies. Addressing these inequities is essential for narrowing the disparate results of COVID-19 going ahead in addition to for stopping comparable disparities related to future public well being threats.

Leave a Comment